Journal Home
Search for

Volume 97, Issue 1, Pages 37-45 (January 2003)


View previous. 7 of 18 View next.

Systematic assessment of clinical practice guidelines for the management of chronic obstructive pulmonary disease

B.J SMITHaf1, K HENDERa, P FRITHb, A.J CROCKETTc, F CHEOKd, S SPEDDINGa

Abstract 

Objective: To systematically evaluate the quality of the development of guidelines for the management of chronic obstructive pulmonary disease (COPD). Methodology: MEDLINE and Excerpta Medica search for published guidelines, followed by independent evaluation by two reviewers, according to previously reported guideline development quality criteria, on a three-point scale. Results: Five national COPD guidelines and two international COPD guidelines were retrieved. Reviewers demonstrated good inter-observer agreement in assessing the 10 combined guideline development criteria for the seven guidelines [κ=0.66]. Guidelines were only partly multi-disciplinary, with little or no consumer input, were up to 48 pages in length, and often lacked practical summaries or management flow charts which could have facilitated retrieval of key management recommendations. Almost all the papers were based upon a consensus approach, rather than evidence based, and methods of resolution of differences of opinion were not stated. Patient outcomes, ethical and medico-legal implications were not addressed and six of the guidelines were sponsored directly or indirectly by a single drug company. Conclusions: In spite of COPD guidelines being reported by major national bodies for over a decade now, most fail to meet important criteria for high-quality guideline development, and evaluation of clinical impact remains undetermined.

No full text is available. To read the body of this article, please view the PDF online.

Article Outline

Abstract

References

Copyright

References 

return to Article Outline
REFERENCES

1. 1 Hurwitz B, Richardson R. Swearing to care: the resurgence in medical oaths. BMJ. 1997;315:1671–1674.

2. 2 Lewis CE. Variations in the incidence of surgery. N Eng J Med. 1969;281:880–884.

3. 3 Wennberg J, Gittelsohn . Small area variations in health care delivery. Science. 1973;182:1102–1108. MEDLINE

4. 4 Stockwell H, Vayda E. Variations in surgery in Ontario. Med Care. 1979;17:390–396. MEDLINE | CrossRef

5. 5 Roos NP. Hysterectomy: variations in rates across small areas and across physician's practices. Am J Public Health. 1984;74:327–335. MEDLINE | CrossRef

6. 6 Chassin MR, Brook RH, Park RE. Variations in the use of medical and surgical services by the Medicare population. N Eng J Med. 1986;314:285–290.

7. 7 Shaneyfelt TM, Mayo-Smith MF, Rothwangl J. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA. 1999;281:1900–1905. MEDLINE | CrossRef

8. 8 Worrall G, Chaulk P, Freake D. The effects of clinical practice guidelines on patient outcomes in primary care: a systematic review. Can Med Asso J. 1997;156:1705–1712.

9. 9 Grilli R, Magrini N, Penna A, Mura G, Liberati A. Practice guidelines developed by specialty societies: the need for critical appraisal. Lancet. 2000;355:103–106. CrossRef

10. 10 Tunis SR, Hayward RS, Wilson MC. Internist's attitudes about clinical practice guidelines. Ann Intern Med. 1994;120:956–963. MEDLINE

11. 11 Grol R, Grimshaw J. Evidence-based implementation of evidence-based medicine. Jt Comm J Qual Improv. 1999;25:503–513. MEDLINE

12. 12 Shekelle PJ, Woolf SH, Eccles M, Grimshaw J. Developing guidelines. BMJ. 1999;318:593–596.

13. 13 Freemantle N, Harvey E, Wolf F, Grimshaw J, Grilli R, Bero LA. Printed educational materials: effects on professional practice and health care outcomes. [Cochrane Review]. Cochrane Database Syst Rev. 1999;2:.

14. 14 Fabbri L, Caramori G, Beghe B, Papi A, Ciaccia A. Chronic obstructive pulmonary disease international guidelines. [Review]. Curr Opin Pulm Med. 1998;4:76–84. MEDLINE

15. 15 World Health Organisation (WHO), World Health Report [Web Page], http://www.who.int/whr/1999/en/pdf/whr99.pdf, (Accessed 17 May 2000)

16. 16 Ward JE, Grieco V. Why we need guidelines for guidelines: a study of the quality of clinical practice guidelines in Australia. Med J Aust. 1996;165:574–576.

17. 17 Graham ID, Calder LA, Herbert PC, Carter AO, Tetroe JM. A comparison of clinical practice guideline appraisal instruments. Int J Technol Assess Health Care. 2000;16:1024–1038. MEDLINE | CrossRef

18. 18 Barratt A, Bates PW. O tell me the truth about evidence [editorial]. ANZ J Public Health. 1997;21:441–444.

19. 19 American Thoracic S ociety. Attributes of ATS documents that guide clinical practice—recommendations of the ATS clinical practice committee. Am J Respir Crit Care Med. 1997;156:2015–2025.

20. 20 Hurwitz B. Legal and political considerations of clinical practice guidelines. BMJ. 1999;318:661–664.

21. 21 NHMRC, AVCC, Joint NHMRC (National Health and Medical Research Council)/ AVCC (Australian Vice-Chancellors Committee) statement and guidelines on research practice, 1997

22. 22 Stelfox HT, Chua G, O'Rourke K, Detsky AS. Conflict of interest in the debate over calcium-channel antagonists. N Eng J Med. 1998;338:101–106.

23. 23 Altman DG. Practical Statistics for Medical Research. London: Chapman & Hall; 1991;.

24. 24 Can Med Assoc J. 1992;147:420–428.

25. 25 Euro Respir J. 1995;8:1398–1420.

26. 26 Am J Respir Crit Care Med. 1995;152:S77–S121.

27. 27 Soc Am Med J. 1998;88:999–1010.

28. 28 Mod Med Aust. 1995;38:132–146.

29. 29 National Institute of Health, Global Strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Global Initiative for Chronic Obstructive Lung Disease. NHLBI/WHO Workshop Report, 2001

30. 30 Thorax. 1997;52:S1–S28. CrossRef

31. 31 Eccles M, Freemantle N, Mason J. North of England evidence based guidelines development project: methods of developing guidelines for efficient drug use in primary care. BMJ. 1998;316:1232–1235.

32. 32 Eccles M, Clapp Z, Grimshaw J. North of England evidence based guidelines development project: methods of guideline development. BMJ. 1996;312:760–762.

33. 33 Celli BR. Current thoughts regarding treatment of chronic obstructive pulmonary disease. [Review]. Med Clin North Am. 1996;80:589–609. MEDLINE

34. 34 Miller J, Petrie J. Development of practice guidelines. Lancet. 2000;355:82–83. CrossRef

35. 35 Eccles M, Clapp Z, Grimshaw J. Developing valid guidelines: methodological and procedural issues from the North of England Evidence Based Guideline Development Project. Qual Health Care. 1996;5:44–50. MEDLINE

36. 36 Feder G, Eccles M, Grol R, Griffiths C, Grimshaw J. Using clinical guidelines. BMJ. 1999;318:728–730.

37. 37 Grol R, Dalhuijsen J, Thomas S, Veld C, Rutten G, Mokkink H. Attributes of clinical guidelines that influence use of guidelines in general practice: observational study. BMJ. 1998;317:858–861.

38. 38 Greco PJ, Eisenberg JM. Changing physicians' practices. N Eng J Med. 1993;329:1271–1273.

39. 39 Iscoe NA. We may get this horse to water, but will it drink?. Can Med Assoc J. 1998;158:345–346.

40. 40 Gray J, Muir A. Evidence-based, locally owned, patient-centred guideline development. Br J Surg. 1997;84:1636–1637. MEDLINE | CrossRef

41. 41 Sackett D. Guidelines and killer B's. ACP J Club. 1999;131:A13–A14. MEDLINE

42. 42 Bastian H. Allies or enemies? Evidence-based medicine and consumer choice. Med J Aust. 2000;172:5–6.

43. 43 Hyams AL, Brandenburg JA, Lipsitz SR, Shapiro DW, Brennan TA. Practice guidelines and malpractice litigation: a two-way street. Ann Intern Med. 1995;122:450–455. MEDLINE

44. 44 Ashton CM, Kuykendall DH, Johnson ML, Wray NP, Wu L. The association between the quality of inpatient care and early readmission. Ann Intern Med. 1995;122:415–421. MEDLINE

45. 45 Kong GK, Belman MJ, Weingarten S. Reducing length of stay for patients hospitalised with exacerbations of COPD by using a practice guideline. Chest. 1997;111:89–94. MEDLINE | CrossRef

46. 46 Mushlin AI, Black ER, Connolly CA, Buonaccoroso KN, Eberly SW. The necessary length of hospital stay for chronic pulmonary disease. JAMA. 1991;266:80–83. MEDLINE

a Clinical Epidemiology and Health Outcomes Unit, The Queen Elizabeth Hospital, SA, Australia

c Respiratory Departments, Flinders Medical Centre, SA, Australia

b Repatriation General Hospital, SA, Australia

d Health Outcomes Unit, Epidemiology Branch, Department of Human Services, SA, Australia

f1 Correspondence should be addressed to: Associate Prof. Brian Smith, Director, Clinical Epidemiology and Health Outcomes Unit, The Queen Elizabeth Hospital, 28 Woodville Road, Woodville South, SA. 5011, Australia. Fax: 08 8222 6042; E-mail: brian.smith@nwahs.sa.gov.au

PII: S0954-6111(02)91417-4

doi:10.1053/rmed.2002.1417


View previous. 7 of 18 View next.